Your Guide to Patient Information

Wegovy (semaglutide) can be accessed for as low as $0 with private or commercial insurance coverage. To access this savings card, visit the Wegovy savings card page on the NovoCare website. Here, you can learn more about the eligibility criteria and apply for the savings card directly.

Details about how to save on Ozempic (semaglutide) can be found on the Ozempic Savings and Resources page. This resource outlines the application process and eligibility requirements. It's important to note that Ozempic is currently FDA-approved for the treatment of Type 2 diabetes, not weight loss. Therefore, only those who have been prescribed Ozempic for the treatment of Type 2 diabetes are eligible for the savings card.

If you have commercial insurance that doesn’t offer coverage for Zepbound/Mounjaro (tirzepatide), you may be able to pay as low as $550 per month. If your insurance does cover Zepbound but still requires that you pay for a percentage of the medication, you may be able to access the medication for as low as $25 out of pocket. To explore these savings options and check your eligibility, visit the Zepbound Coverage Savings page and the Mounjaro savings page. 

Rybelsus (semaglutide) offers support and savings for eligible patients. By visiting the Rybelsus Savings and Support page, patients can access information on how to apply for a savings card, alongside other supportive resources to help manage their condition effectively.

Victoza (liraglutide) has established a support and savings page for patients requiring assistance with their medication costs. By navigating to the Victoza Support and Savings page, patients can find detailed information on how to access these savings, ensuring they receive the necessary support for their weight management journey.

Saxenda (liraglutide) offers a savings card for eligible patients that can potentially reduce the cost significantly. Visit the Saxenda savings card page to learn more about the offer and to apply.